Genzyme Corp. has received U.S. regulatory approval to market the drug Lumizyme, a treatment for Pompe disease.
National Business News - Local Business News | bizjournals, Biz Journals
Wed, 05/26/2010 - 6:28am
Genzyme Corp. has received U.S. regulatory approval to market the drug Lumizyme, a treatment for Pompe disease.